A Serum Calprotectin Lateral Flow Test As an Inflammatory and Prognostic Marker in Acute Lung Infection: a Prospective Observational Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
https://bit.ly/48e1BIv.
References
1.
Nicolai L, Leunig A, Brambs S, Kaiser R, Joppich M, Hoffknecht M
. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J Thromb Haemost. 2020; 19(2):574-581.
PMC: 7753335.
DOI: 10.1111/jth.15179.
View
2.
Sprenkeler E, Zandstra J, van Kleef N, Goetschalckx I, Verstegen B, Aarts C
. S100A8/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation. Cells. 2022; 11(2).
PMC: 8773660.
DOI: 10.3390/cells11020236.
View
3.
Aschenbrenner A, Mouktaroudi M, Kramer B, Oestreich M, Antonakos N, Nuesch-Germano M
. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 2021; 13(1):7.
PMC: 7805430.
DOI: 10.1186/s13073-020-00823-5.
View
4.
Keir H, Shoemark A, Dicker A, Perea L, Pollock J, Giam Y
. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021; 9(8):873-884.
DOI: 10.1016/S2213-2600(20)30504-X.
View
5.
Meizlish M, Pine A, Bishai J, Goshua G, Nadelmann E, Simonov M
. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021; 5(5):1164-1177.
PMC: 7908851.
DOI: 10.1182/bloodadvances.2020003568.
View